Rxsight Stock Based Compensation from 2010 to 2025

RXST Stock

USD 26.56 0.11 0.41%

Rxsight Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation will likely drop to about 12.5 M in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2020-03-31

Previous Quarter

6.6 M

Current Value

7.3 M

Quarterly Volatility

1.9 M

Covid

Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 30.8 K, Net Interest Income of 9.9 M or Interest Income of 9.9 M, as well as many indicators such as Price To Sales Ratio of 9.07, Dividend Yield of 0.0 or PTB Ratio of 4.99. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.

Check out the analysis of Rxsight Correlation against competitors.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Latest Rxsight's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Rxsight over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Rxsight's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rxsight's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Rxsight Stock Based Compensation Regression Statistics

	Arithmetic Mean	7,625,600
	Geometric Mean	6,372,447
	Coefficient Of Variation	75.46
	Mean Deviation	4,220,900
	Median	4,598,000
	Standard Deviation	5,754,221
	Sample Variance	33.1T
	Range	20.4M
	R-Value	0.71
	Mean Square Error	17.7T
	R-Squared	0.50
	Significance	0
	Slope	855,115
	Total Sum of Squares	496.7T

Rxsight Stock Based Compensation History

	2025	12.5 M
	2024	24.6 M
	2023	15.7 M
	2022	11.4 M
	2021	7.6 M
	2020	4.2 M

Other Fundumenentals of Rxsight

Stock Based Compensation To Revenue

Rxsight Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt	Long Term Debt Total	Capital Surpluse
Total Assets		0.87	0.82	0.85	0.02	-0.83	0.79	0.85	1.0	-0.82	0.86	1.0	-0.81	1.0	0.21	-0.81	-0.85	0.89	-0.61	0.9
Total Stockholder Equity	0.87		0.98	0.9	0.23	-0.95	0.67	0.91	0.85	-0.98	1.0	0.89	-0.96	0.88	0.46	-0.96	-0.97	0.98	-0.67	0.77
Net Tangible Assets	0.82	0.98		0.8	0.36	-0.9	0.6	0.82	0.79	-1.0	0.99	0.84	-0.98	0.83	0.62	-0.98	-0.99	0.99	-0.53	0.65
Current Deferred Revenue	0.85	0.9	0.8		-0.08	-0.98	0.8	1.0	0.82	-0.83	0.88	0.85	-0.79	0.83	0.1	-0.79	-0.81	0.81	-0.85	0.92
Net Debt	0.02	0.23	0.36	-0.08		-0.07	-0.35	-0.06	-0.01	-0.33	0.28	0.04	-0.26	0.03	0.87	-0.26	-0.36	0.34	0.2	-0.14
Retained Earnings	-0.83	-0.95	-0.9	-0.98	-0.07		-0.76	-0.98	-0.79	0.92	-0.94	-0.84	0.88	-0.82	-0.29	0.88	0.9	-0.88	0.76	-0.84
Accounts Payable	0.79	0.67	0.6	0.8	-0.35	-0.76		0.79	0.79	-0.63	0.64	0.79	-0.67	0.78	-0.03	-0.67	-0.66	0.64	-0.48	0.8
Net Receivables	0.85	0.91	0.82	1.0	-0.06	-0.98	0.79		0.82	-0.84	0.89	0.86	-0.8	0.84	0.12	-0.8	-0.83	0.82	-0.83	0.91
Short Term Investments	1.0	0.85	0.79	0.82	-0.01	-0.79	0.79	0.82		-0.79	0.84	0.99	-0.79	1.0	0.18	-0.79	-0.82	0.87	-0.59	0.88
Total Liab	-0.82	-0.98	-1.0	-0.83	-0.33	0.92	-0.63	-0.84	-0.79		-0.99	-0.84	0.97	-0.83	-0.59	0.97	0.99	-0.98	0.54	-0.67
Net Invested Capital	0.86	1.0	0.99	0.88	0.28	-0.94	0.64	0.89	0.84	-0.99		0.88	-0.96	0.87	0.5	-0.96	-0.98	0.98	-0.64	0.75
Total Current Assets	1.0	0.89	0.84	0.85	0.04	-0.84	0.79	0.86	0.99	-0.84	0.88		-0.82	1.0	0.24	-0.82	-0.87	0.9	-0.6	0.89
Capital Stock	-0.81	-0.96	-0.98	-0.79	-0.26	0.88	-0.67	-0.8	-0.79	0.97	-0.96	-0.82		-0.82	-0.59	1.0	0.96	-0.96	0.52	-0.64
Net Working Capital	1.0	0.88	0.83	0.83	0.03	-0.82	0.78	0.84	1.0	-0.83	0.87	1.0	-0.82		0.23	-0.82	-0.85	0.9	-0.59	0.88
Short Term Debt	0.21	0.46	0.62	0.1	0.87	-0.29	-0.03	0.12	0.18	-0.59	0.5	0.24	-0.59	0.23		-0.59	-0.61	0.58	0.18	-0.05
Common Stock	-0.81	-0.96	-0.98	-0.79	-0.26	0.88	-0.67	-0.8	-0.79	0.97	-0.96	-0.82	1.0	-0.82	-0.59		0.96	-0.96	0.52	-0.64
Property Plant Equipment	-0.85	-0.97	-0.99	-0.81	-0.36	0.9	-0.66	-0.83	-0.82	0.99	-0.98	-0.87	0.96	-0.85	-0.61	0.96		-0.99	0.48	-0.69
Long Term Debt	0.89	0.98	0.99	0.81	0.34	-0.88	0.64	0.82	0.87	-0.98	0.98	0.9	-0.96	0.9	0.58	-0.96	-0.99		-0.52	0.71
Long Term Debt Total	-0.61	-0.67	-0.53	-0.85	0.2	0.76	-0.48	-0.83	-0.59	0.54	-0.64	-0.6	0.52	-0.59	0.18	0.52	0.48	-0.52		-0.82
Capital Surpluse	0.9	0.77	0.65	0.92	-0.14	-0.84	0.8	0.91	0.88	-0.67	0.75	0.89	-0.64	0.88	-0.05	-0.64	-0.69	0.71	-0.82

Click cells to compare fundamentals

About Rxsight Financial Statements

Rxsight shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	24.6 M	12.5 M
Stock Based Compensation To Revenue	0.20	0.19

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rxsight Stock Based Compensation from 2010 to 2025

Latest Rxsight's Stock Based Compensation Growth Pattern

Rxsight Stock Based Compensation Regression Statistics

Rxsight Stock Based Compensation History

Other Fundumenentals of Rxsight

Rxsight Stock Based Compensation component correlations

About Rxsight Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Rxsight Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY